Penumbra (PEN) Revenue (2014 - 2026)
Penumbra's (PEN) quarterly Revenue came in at $374.8 million in Q1 2026, up 15.62% year-on-year from $324.1 million in Q1 2025, and down 2.76% on a QoQ basis from $385.4 million in Q4 2025.
Penumbra (PEN) Revenue (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Revenue data on file, last reported at $374.8 million in Q1 2026.
- On a quarterly basis, Revenue rose 15.62% year-over-year to $374.8 million in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 17.27% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 17.5% from the prior year.
- Revenue for Q1 2026 stood at $374.8 million, down from $385.4 million in the prior quarter.
- Over the last five years, Revenue for PEN reached as high as $385.4 million in Q4 2025 and fell as low as $203.9 million in Q1 2022.
- Historically, Revenue has averaged $287.0 million across 5 years, with a median of $284.7 million in 2023.
- Across the five-year window, Revenue advanced 8.43% in 2022 and increased 28.69% in 2023, its largest moves.
- Year by year, Revenue stood at $221.2 million in 2022, then grew by 28.69% to $284.7 million in 2023, then gained by 10.83% to $315.5 million in 2024, then climbed by 22.14% to $385.4 million in 2025, then dropped by 2.76% to $374.8 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $374.8 million in Q1 2026, $385.4 million in Q4 2025, and $354.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.19 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.57 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 374.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 374.76 Mn |
| Dec 31, 2025 | 385.39 Mn |
| Sep 30, 2025 | 354.69 Mn |
| Jun 30, 2025 | 339.46 Mn |
| Mar 31, 2025 | 324.14 Mn |
| Dec 31, 2024 | 315.52 Mn |
| Sep 30, 2024 | 301.04 Mn |
| Jun 30, 2024 | 299.40 Mn |
| Mar 31, 2024 | 278.66 Mn |
| Dec 31, 2023 | 284.68 Mn |
| Sep 30, 2023 | 270.95 Mn |
| Jun 30, 2023 | 261.50 Mn |
| Mar 31, 2023 | 241.40 Mn |
| Dec 31, 2022 | 221.22 Mn |
| Sep 30, 2022 | 213.68 Mn |
| Jun 30, 2022 | 208.34 Mn |
| Mar 31, 2022 | 203.90 Mn |
| Dec 31, 2021 | 204.01 Mn |
| Sep 30, 2021 | 190.12 Mn |
| Jun 30, 2021 | 184.26 Mn |